文献速递免疫规划卫生政策与健康促进

中国上海家长疫苗偏好的联合分析

A conjoint analysis of stated vaccine preferences in Shanghai, China.
PubMed 文献 · Vaccine · 2019-12-09

2017年在上海免疫接种门诊调查≤3月龄婴儿家长对疫苗属性的偏好,采用离散选择实验向599名照护者呈现假设疫苗方案,用逻辑回归估计偏好效用。家长对30%发热风险、仅85%效力、进口疫苗及未在中国儿童中测试的疫苗偏好更低;较富裕群体偏好更贵疫苗,较不富裕群体未表现出基于费用的偏好。

要点

  • 家长对30%发热风险疫苗的偏好低于10%发热风险疫苗(OR 0.53)。
  • 家长对仅85%效力疫苗的偏好低于95%效力疫苗(OR 0.55)。
  • 家长对进口疫苗及未在中国儿童中测试疫苗的偏好更低。

核心结论

  • 中国家长对疫苗的偏好包括曾在中国儿童中测试,而这是中国所有获批疫苗的既有要求。
  • 作者认为中国疫苗推广应关注家长陈述的偏好,试验信息可强调低不良事件风险和高效力。

研究设计与样本

  • 2017年在上海免疫接种门诊对≤3月龄婴儿家长进行离散选择实验(DCE)调查。
  • 共599名照护者完成DCE,疫苗属性包括费用、副作用风险、生产商所在地、疫苗测试、效力、疾病严重程度和疾病患病率。
  • 采用逻辑回归估计偏好效用。

主要发现

  • 与10%发热概率相比,家长对30%发热概率疫苗的偏好更低(OR 0.53,95%CI 0.44-0.64)。
  • 与95%效力疫苗相比,家长对仅85%效力疫苗的偏好更低(OR 0.55,95%CI 0.48-0.62)。
  • 与国产疫苗相比,家长对进口疫苗(OR 0.74,95%CI 0.60-0.92)和未在中国儿童中测试的疫苗(OR 0.45,95%CI 0.37-0.53)偏好更低。
  • 较富裕群体偏好更昂贵的疫苗,而较不富裕群体未表现出基于费用的偏好。

临床怎么用

  • 作者认为中国疫苗推广应关注家长陈述的偏好,包括曾在中国儿童中测试。
  • 作者认为关于这些试验的信息可强调低不良事件风险和高效力。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

It is not clear what kind of preferences parents in China would have for vaccines that could be added to a future immunization schedule. This study's aim was to assess Chinese parents' preferences for attributes of vaccines. We surveyed parents of young infants ≤3 months of age at immunization clinics in Shanghai, China, in 2017. We used a discrete choice experiment (DCE) to present parents with choices between two hypothetical profiles of vaccines which were described using the following attributes: cost, risk of side effect, location of vaccine manufacturer, vaccine testing, vaccine effectiveness, severity of disease, disease prevalence. A logistic regression output estimates of preference utilities. In total, 599 caregivers completed the DCE. Parents expressed lower preference for vaccines with a 30% chance of fever as an adverse event vs a 10% chance (OR: 0.53, 95% CI: 0.44, 0.64), for vaccines only 85% effective vs those 95% effective (OR: 0.55, 95% CI: 0.48, 0.62), and for imported vaccines (OR: 0.74, 95% CI: 0.60, 0.92) and those not tested in Chinese children (OR: 0.45, 95% CI: 0.37, 0.53) compared to domestic vaccines. More affluent groups preferred more expensive vaccines whereas less affluent groups did not express cost-based preferences. Promotion of vaccines in China should focus on parents' stated preferences, which include past testing done in Chinese children - which is, in fact, required of all licensed vaccines in China. Information about these trials could emphasize low risk of adverse events and high effectiveness.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Sun X, Wagner AL, Ji J, et al. A conjoint analysis of stated vaccine preferences in Shanghai, China. Vaccine. 2019. PMID: 31822426. doi:10.1016/j.vaccine.2019.11.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。